About Index Trending news
Lists
Pricing
Merck Ventures

Merck Ventures

Elsewhere

Alexa global traffic share

Twitter followers

Activity

Past year's investments
  • 8 rounds in the past year
  • $148,148,622 deployed in total
  • $18,518,578 avg per round
Latest rounds
  • aveni: Venture capital (Series B) (€8.9M)
  • Peratech: Venture capital ($12.4M)
  • LifeMine Therapeutics: Venture capital (Series A) ($55M)
Total funding
$21.5M in 4 rounds from 17 investors
By Merck Ventures
$14.5M Series B in Mar, 2017
Total funding
$24M in 2 rounds from 6 investors
By Merck Ventures
€8.9M Series B in Oct, 2017
Total funding
$42.4M in 2 rounds from 5 investors
By Merck Ventures
$11.9M Series B in Jul, 2016
Total funding
$17.4M in 1 rounds from 4 investors
By Merck Ventures
£12M Series A in Jun, 2016
Total funding
$17.4M in 1 rounds from 4 investors
By Merck Ventures
£12M Series A in Jun, 2016
Total funding
$33.2M in 1 rounds from 6 investors
By Merck Ventures
$33.2M Series A in Sep, 2016
Total funding
$6.3M in 1 rounds from 4 investors
By Merck Ventures
$6.3M Series A in Jan, 2017
Total funding
$11.1M in 2 rounds from 4 investors
By Merck Ventures
undisclosed deal in Aug, 2017
Total funding
$41.2M in 2 rounds from 6 investors
By Merck Ventures
€29M Series B in Feb, 2017
Total funding
$11.5M in 1 rounds from 4 investors
By Merck Ventures
$11.5M Series A in Jun, 2017
Total funding
$55M in 1 rounds from 8 investors
By Merck Ventures
$55M Series A in Sep, 2017
Total funding
$16.3M in 1 rounds from 5 investors
By Merck Ventures
€11M Series A in Sep, 2017
Total funding
$12.4M in 1 rounds from 2 investors
By Merck Ventures
$12.4M Venture Capital in Oct, 2017

Want to see the complete list?
Go Pro!